Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Drug Dependence: later-stage trial registry
A small indexed set (10 trials) with no open enrollment listed right now.
Corpus placement: #1,724 of 28,707 conditions by registered trial count.
10 US clinical trials · none currently recruiting · #1,724 of 28,707 conditions by registered trial count
Drug Dependence: 10 US clinical trials tracked, none currently recruiting.
Drug Dependence is the subject of 10 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 3 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Yale University, running 3 of these trials.
Enrollment posture brief
Registry condition drug-dependence
OPEN 0 | RECR 0% | LATE 3 | EARLY 1 | RANK #1724 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Drug Dependence has no open enrollment in this registry pull (10 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Drug Dependence on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Drug Dependence is recruiting below its size-band peers.
0 of 10 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Drug Dependence research.
Yale University accounts for 3 of 10 trials (30%). 8 distinct sponsors appear on at least one study for this condition label.
-
Typical Drug Dependence enrolment sits around 159 participants.
Median target enrolment is 159 among the 10 trials that report a genuine target (sentinel values excluded). 4 of those (40%) plan for fewer than 100 participants.
-
Drug Dependence research is mostly interventional.
8 interventional and 2 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Indexed trials (enrollment closed)
10 total, page 1 of 1
CB1R in Synthetic Psychoactive Cannabinoids
Yale University
NCT03539575
The Effect of Fetal Gender on Maternal Substance Abuse Treatment
Johns Hopkins University
NCT00882648
Assessing Screening Plus Brief Intervention's Resulting Efficacy (ASPIRE) to Stop Drug Use
Boston Medical Center
NCT00876941
Making Alcoholics Anonymous Easier
Alcohol Research Group
NCT01382316
Intensive Outpatient Versus Outpatient Treatment With Buprenorphine Among African Americans
Friends Research Institute
NCT01096550
HIV, Buprenorphine, and the Criminal Justice System (STRIDE2)
Yale University
NCT03583138
Innovative Digital Therapeutic for Smoking Cessation
My Digital Study
NCT03694327
Integrated Treatment of OEF/OIF Veterans With PTSD & Substance Use Disorders
Medical University of South Carolina
NCT01338506
Integration of Buprenorphine Into HIV Clinical Settings - Primary Care Model (PCM)
Yale University
NCT00798538
Drug Discrimination in Methadone-Maintained Humans Study 3
University of Arkansas
NCT01068847
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 3 | 2 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Drug Dependence records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Drug Dependence trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Drug Dependence page
10 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Drug Dependence trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Yale University sponsors the most Drug Dependence trials on record, review their full trial history before evaluating a specific study. See Yale University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Drug Dependence condition card totals 10 registered trials; most-linked intervention Services remain dispersed; i.e., not centralized to one-location or provider.; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.